Atossa Genetics Inc buy Cantor Fitzgerald
Start price
20.06.24
/
50%
€1.03
Target price
20.06.25
-
Performance (%)
28.66%
Price
10.09.24
€1.32
Summary
This prediction is currently active. The prediction currently has a performance of 28.66%. This prediction currently runs until 20.06.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Atossa Genetics Inc | 9.091% | 9.091% |
iShares Core DAX® | -1.611% | 3.135% |
iShares Nasdaq 100 | -0.500% | 0.775% |
iShares Nikkei 225® | -1.483% | 4.610% |
iShares S&P 500 | -0.501% | 1.914% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Atossa Genetics Inc diskutieren
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for ATOS provided by MarketBeat